Treatment-resistant arterial hypertension revealing giant cell arteritis: A case report
Dr Lakrafi Yassir1, Professor Mina Moudatir2, Professor Khadija Echchilali2
1Internal Medicine Department and Geriatrics Unit of the Ibn Rochd University Hospital Center in Casablanca, Morocco.
Background:
Giant cell arteritis (formerly Horton's disease) is an inflammatory large-vessel vasculitis of unknown etiology, primarily affecting individuals over 50 years of age, with a female predominance. Its clinical manifestations are heterogeneous and non-specific, making diagnosis challenging. Histological confirmation by temporal artery biopsy or alternatively 18F-FDG PET/CT when the biopsy isn't possible, remains the diagnostic gold standard.
Methods/Discussion:
We report a case highlighting the diagnostic complexity of this condition: a 68-year-old man with no significant medical history, regularly monitored through annual check-ups, who presented with new-onset arterial hypertension associated with persistent headaches. Blood pressure remained uncontrolled despite antihypertensive therapy. The patient subsequently developed significant general deterioration and a prolonged inflammatory syndrome. The diagnosis of Giant cell arteritis was ultimately confirmed through histology, CT angiography, and PET/CT imaging.
Conclusion:
Giant cell arteritis does not always present with scalp paresthesia, headache, jaw claudication, or ocular involvement; refractory arterial hypertension associated with a deterioration in general condition should also raise suspicion, as illustrated by our case.
More Related Videos
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Aneurysm III: Interprofessional Care
Aortic Regurgitation III: Medical Management
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Antihypertensive Drugs: Angiotensin II Receptor Blockers


